Clinical Trial Update: Topical Erythropoietin Hydrogel Formulation for Diabetic Foot Ulcers [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for a topical erythropoietin hydrogel in diabetic foot ulcers completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Topical erythropoietin hydrogel (erythropoietin hydrogel)

Snippet

Sponsor: Remedor Biomed Ltd | Conditions: Diabetic Foot Ulcer | Phase 1, Phase 2 | Status: COMPLETED